< Back to previous page
Researcher
Nick Devoogdt
- Keywords:Medicine, Applied biological sciences, biotechnology
- Disciplines:Cancer therapy, Radiopharmacy, Biomarker evaluation, Nuclear imaging, Molecular diagnostics, Medical molecular engineering of nucleic acids and proteins, Medical biotechnology diagnostics, Applied immunology, Non-clinical studies, Industrial molecular engineering of nucleic acids and proteins, Cancer diagnosis
Affiliations
- Medical Imaging (Research group)
Member
From1 Jan 2011 → Today - Supporting clinical sciences (Department)
Member
From1 Oct 2021 → Today - Supporting clinical sciences (Department)
Member
From8 Apr 2019 → 30 Sep 2021 - Supporting clinical sciences (Department)
Member
From1 Jan 2014 → 20 Oct 2022 - Supporting clinical sciences (Department)
Member
From1 Mar 2013 → 31 Dec 2017 - Medical Imaging and Physical Sciences (Department)
Member
From1 Mar 2013 → 31 Dec 2013 - Medical Imaging and Physical Sciences (Department)
Member
From1 Oct 2007 → 30 Sep 2009 - Cellular and Molecular Immunology (Research group)
Member
From1 Oct 1999 → 30 Sep 2007 - Department of Bio-engineering Sciences (Department)
Member
From1 Oct 1997 → 28 Feb 2013
Projects
1 - 10 of 34
- Exploiting Peptides as Protein Binders, Modulators, Inhibitors and Biomaterials for Imaging and Therapy [Exploit-PeptIT]From1 Mar 2024 → TodayFunding: BOF - projects
- Development of a bispecific immunotracer against CD8 and CD69 for enhanced non-invasive imaging of immune responses during anti-cancer immunotherapyFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Development of automated enzyme-mediated bioconjugations as a technology to produce smallprotein-based radiopharmaceuFrom1 Oct 2023 → TodayFunding: FWO junior postdoctoral fellowship
- MATRACs: Membrane Anchoring TRAfficking ChimerasFrom1 Jan 2023 → TodayFunding: BOF - iBOF
- INVISIBLE: Investigation and inhibition of Epstein-Barr Virus immune evasion by BILF1-modulating nanobodiesFrom1 Nov 2022 → TodayFunding: FWO junior postdoctoral fellowship
- SRP-Onderzoekszwaartepunt: ITAREG: Molecular Imaging and TArgeting of immunoREGulatory cells in Inflammatory diseases and cancerFrom1 Nov 2022 → TodayFunding: BOF - projects
- IOF Accelerator:Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)From1 Oct 2022 → 31 Mar 2024Funding: IOF - technology validation in real environment
- IOF POC Project SYNALI : Development and application of a Synthetic Nanobody LibraryFrom1 Jan 2022 → TodayFunding: IOF - technology concept exploration
- Nanobody-based AXL targeting and combination treatment for acute myeloid leukemia and multiple myelomaFrom1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
- Evaluation of an in vivo pre-targeting approach for targeted radionuclide therapy of cancer using clickable anti-B7-H3 single domain antibodies.From1 Nov 2021 → TodayFunding: FWO fellowships
Patents
1 - 10 of 10
- Anti-vcam-1 nanobodies (Inventor)
- Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells (Inventor)
- Anti-macrophage mannose receptor single variable domains for use in cardiovascular diseases (Inventor)
- Radio-labelled antibody fragments for use in the prevention and/or treatment of cancer (Inventor)
- Radiolabelled antibody fragments for use in treating cancer (Inventor)
- Anti lag3 vhhs and their use (Inventor)
- Radiolabelled antibody fragments for use in treating cancer (Inventor)
- Anti-macrophage mannose receptor immunoglobulin single variable domains for targeting and in vivo imaging of tumor-associated macrophages (Inventor)
- Anti-dpp6 chimeric antigen receptor bearing regulatory t cells (Inventor)
- Anti lag3 vhhs and their use (Inventor)